Here’s how our Neurological Institute is working to counter national trends of burnout and leadership inequity among women in medicine, with a focus on the role psychologists can play in such efforts.
Read MoreNeurotrauma Guidelines: Where They’ve Been, Where They’re Headed and How to Make the Most of Them
A neurosurgeon deeply involved with the Brain Trauma Foundation’s guidelines for head injuries shares insights on the essentials of management and what research in the field is focusing on.
Autoimmune Neurologic Disorders: Treatable Conditions That Should Not Be Missed
While recognition of autoimmune encephalitis has increased substantially, autoimmune causality is still overlooked for many subtle neurologic abnormalities. A subspecialist provides an update on autoimmune neurology.
Emerging Blood-Based Biomarkers for Alzheimer Disease: A Status Report
A screening blood test could accelerate drug development and enable earlier, more effective intervention. We offer an overview of promising efforts in pursuit of a reliable blood-based biomarker.
Multimodal Monitoring in the Neuro ICU: Essentials for Clinicians (Podcast)
Multimodal monitoring has reached the point where standards and guidelines are starting to be developed. A leading neurointensivist explains what this approach involves and where it’s likely headed.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
More Patients Can Benefit From Functional Interventions for Parkinson’s, Essential Tremor (Podcast)
Only about 10% of candidates for surgical intervention for movement disorders end up undergoing surgery. Our latest podcast discusses new approaches that may increase that percentage.
The Importance of Screening for Frailty in Patients with Spinal Conditions (Podcast)
A medical spine specialist explains why frailty looms especially large in patients with spine disease, why it doesn’t necessarily go hand in hand with age, and proactive ways to reduce it in this population.
New Frontiers in Diagnosing and Monitoring Multiple Sclerosis (Podcast)
Traditional means of monitoring patients with MS are increasingly inadequate. The director of our MS program discusses emerging technologies and research studies to explore their roles.
CGRP Antagonists for Decreasing Migraine Frequency: A Primer
Monthly or quarterly dosing and favorable side-effect profiles make these new medications a welcome addition to the armamentarium for migraine prevention. We share insights on how they fit into practice.
Neurologic Manifestations of COVID-19: More Common Than We Thought (Podcast)
The neurologic effects of COVID-19 continue to expand and are as varied as the mechanisms behind them. Dr. Jeffrey Cohen discusses our latest understanding of these neurologic manifestations and some ongoing related research.
COVID-19 and Movement Disorders: Time to Adopt ‘Adaptive Neurology’
With scarce data on how these conditions affect each other, nimbleness may be the best tool neurologists can deploy when managing movement disorders in this time of pandemic.